» Articles » PMID: 31315247

Repression of the Glucocorticoid Receptor Increases Hypoxic-Ischemic Brain Injury in the Male Neonatal Rat

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Jul 19
PMID 31315247
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Hypoxic-ischemic encephalopathy (HIE) resulting from asphyxia is the most common cause of neonatal brain damage and results in significant neurological sequelae, including cerebral palsy. The current therapeutic interventions are extremely limited in improving neonatal outcomes. The present study tests the hypothesis that the suppression of endogenous glucocorticoid receptors (GRs) in the brain increases hypoxic-ischemic (HI) induced neonatal brain injury and worsens neurobehavioral outcomes through the promotion of increased inflammation. A mild HI treatment of P9 rat pups with ligation of the right common carotid artery followed by the treatment of 8% O for 60 min produced more significant brain injury with larger infarct size in female than male pups. Intracerebroventricular injection of GR siRNAs significantly reduced GR protein and mRNA abundance in the neonatal brain. Knockdown of endogenous brain GRs significantly increased brain infarct size after HI injury in male, but not female, rat pups. Moreover, GR repression resulted in a significant increase in inflammatory cytokines TNF-α and IL-10 at 6 h after HI injury in male pups. Male pups treated with GR siRNAs showed a significantly worsened reflex response and exhibited significant gait disturbances. The present study demonstrates that endogenous brain GRs play an important role in protecting the neonatal brain from HI induced injury in male pups, and suggests a potential role of glucocorticoids in sex differential treatment of HIE in the neonate.

Citing Articles

Risk factors and nomogram for the prediction of intracranial hemorrhage in very preterm infants.

Wang Y, Yang Y, Wen L, Li M BMC Pediatr. 2024; 24(1):793.

PMID: 39633312 PMC: 11616105. DOI: 10.1186/s12887-024-05274-0.


Research advances in huntingtin-associated protein 1 and its application prospects in diseases.

Wu Y, Wang Y, Lu Y, Yan J, Zhao H, Yang R Front Neurosci. 2024; 18:1402996.

PMID: 38975245 PMC: 11224548. DOI: 10.3389/fnins.2024.1402996.


Neuroprotective role of nitric oxide inhalation and nitrite in a Neonatal Rat Model of Hypoxic-Ischemic Injury.

Jung P, Ha E, Zhang M, Fall C, Hwang M, Taylor E PLoS One. 2022; 17(5):e0268282.

PMID: 35544542 PMC: 9094545. DOI: 10.1371/journal.pone.0268282.


Inter-alpha Inhibitor Proteins Ameliorate Brain Injury and Improve Behavioral Outcomes in a Sex-Dependent Manner After Exposure to Neonatal Hypoxia Ischemia in Newborn and Young Adult Rats.

Chen X, Zhang J, Wu Y, Tucker R, Baird G, Domonoske R Neurotherapeutics. 2022; 19(2):528-549.

PMID: 35290609 PMC: 9226254. DOI: 10.1007/s13311-022-01217-8.


Olig2 knockdown alleviates hypoxic-ischemic brain damage in newborn rats.

Yang L, Cui H Histol Histopathol. 2021; 36(6):675-684.

PMID: 34013967 DOI: 10.14670/HH-18-344.


References
1.
Baldan Ramsey L, Pittenger C . Cued and spatial learning in the water maze: equivalent learning in male and female mice. Neurosci Lett. 2010; 483(2):148-51. PMC: 2933314. DOI: 10.1016/j.neulet.2010.07.082. View

2.
Towfighi J, Yager J, Housman C, Vannucci R . Neuropathology of remote hypoxic-ischemic damage in the immature rat. Acta Neuropathol. 1991; 81(5):578-87. DOI: 10.1007/BF00310141. View

3.
Weitzdoerfer R, Pollak A, Lubec B . Perinatal asphyxia in the rat has lifelong effects on morphology, cognitive functions, and behavior. Semin Perinatol. 2004; 28(4):249-56. DOI: 10.1053/j.semperi.2004.08.001. View

4.
Ros-Bernal F, Hunot S, Herrero M, Parnadeau S, Corvol J, Lu L . Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A. 2011; 108(16):6632-7. PMC: 3080980. DOI: 10.1073/pnas.1017820108. View

5.
Parkkinen S, Ortega F, Kuptsova K, Huttunen J, Tarkka I, Jolkkonen J . Gait impairment in a rat model of focal cerebral ischemia. Stroke Res Treat. 2013; 2013:410972. PMC: 3603709. DOI: 10.1155/2013/410972. View